PharmaVoice 100 logo

Retrophin President and Chief Executive Officer Eric Dube Named to the 2020 PharmaVOICE 100

SAN DIEGO (August 3, 2020) – Retrophin,  Inc. (NASDAQ: RTRX) today announced that Eric Dube, Ph.D., president  and chief  executive officer, has been named by PharmaVOICE magazine to the 2020 PharmaVOICE 100 – an award that recognizes the 100 Most Inspiring People in the life sciences industry. Read the press release >
Travere Circle Logo

Retrophin Reports Second Quarter 2020 Financial Results

SAN DIEGO, July 30, 2020 (GLOBE NEWSWIRE) -- Retrophin, Inc. (NASDAQ: RTRX) today reported its second quarter 2020 financial results and provided a corporate update. Read the press release >
Marshall Summar, M.D., CNRDI

Connecting More People to Optimal Rare Disease Care

,
An update on our partnership with Children's National Rare Disease Institute.
Rare Revolution Logo

Eric Dube, Ph.D., Interviewed by Rare Revolution

July 1, 2020 -- Our CEO and president Eric Dube, Ph.D., recently spoke with Rare Revolution Magazine about motivation, inspiration, challenges and hope.